Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Arteether
2. Arteether, (3r-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12ar*))-isomer
3. Arteether, (3r-(3alpha,5abeta,6beta,8abeta,9alpha,10beta,12beta,12ar*))-isomer
4. Artemotil
5. Artether
6. Beta-artether
7. Sm-227
1. Artemotil [inn]
2. Artemotil (inn)
3. Beta Arteether
4. Beta-dihydroartemisinin Ethyl Ether
5. Ethoxy(trimethyl)[?]
6. Xgl7gfb9yi
7. Unii-xgl7gfb9yi
8. Sm 227
9. 109716-83-8
10. Nsc 665971
11. Ethyl-ether-quinghaosu
12. Dsstox_cid_31610
13. Dsstox_rid_97494
14. Dsstox_gsid_57821
15. Schembl1648554
16. Chembl3560584
17. Dtxsid6057821
18. Tox21_113883
19. Ncgc00253770-01
20. 3,12-epoxy-12h-pyrano(4,3-j)-1,2-benzodioxepin, 10-ethoxydecahydro-3,6,9-trimethyl-, (3s-(3alpha,5alpha,6alpha,8aalpha,9beta,10beta,12beta,12aalpha))-
21. 3,12-epoxy-12h-pyrano(4,3-j)-1,2-benzodioxepin, Decahydro-10-ethoxy-3,6,9-trimethyl-, (3r-(3alpha,5abeta,6beta,8abeta,9alpha,10alpha,12beta,12ar*))-
22. Cas-75887-54-6
23. Wr-255131
24. D07361
25. A915244
26. (3r,12ar)-3,6alpha,9beta-trimethyl-10beta-ethoxy-3beta,12alpha-epoxy-3,4,5,5aalpha,6,7,8,8aalpha,9,10-decahydropyrano[4,3-j]-1,2-benzodioxepin
27. 3,12-epoxy-12h-pyrano[4,3-j]-1,2-benzodioxepin, 10-ethoxydecahydro-3,6,9-trimethyl-, (3r,5as,6r,8as,9r,10s,12r,12ar)-
| Molecular Weight | 312.4 g/mol |
|---|---|
| Molecular Formula | C17H28O5 |
| XLogP3 | 3.4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | 312.19367399 g/mol |
| Monoisotopic Mass | 312.19367399 g/mol |
| Topological Polar Surface Area | 46.2 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 443 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 7 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Antimalarials
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)
Schistosomicides
Agents that act systemically to kill adult schistosomes. (See all compounds classified as Schistosomicides.)
Amebicides
Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal. (See all compounds classified as Amebicides.)
Market Place
ABOUT THIS PAGE
74
PharmaCompass offers a list of Arteether API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Arteether manufacturer or Arteether supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Arteether manufacturer or Arteether supplier.
PharmaCompass also assists you with knowing the Arteether API Price utilized in the formulation of products. Arteether API Price is not always fixed or binding as the Arteether Price is obtained through a variety of data sources. The Arteether Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A DSSTox_CID_31610 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of DSSTox_CID_31610, including repackagers and relabelers. The FDA regulates DSSTox_CID_31610 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. DSSTox_CID_31610 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of DSSTox_CID_31610 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A DSSTox_CID_31610 supplier is an individual or a company that provides DSSTox_CID_31610 active pharmaceutical ingredient (API) or DSSTox_CID_31610 finished formulations upon request. The DSSTox_CID_31610 suppliers may include DSSTox_CID_31610 API manufacturers, exporters, distributors and traders.
click here to find a list of DSSTox_CID_31610 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
DSSTox_CID_31610 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of DSSTox_CID_31610 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right DSSTox_CID_31610 GMP manufacturer or DSSTox_CID_31610 GMP API supplier for your needs.
A DSSTox_CID_31610 CoA (Certificate of Analysis) is a formal document that attests to DSSTox_CID_31610's compliance with DSSTox_CID_31610 specifications and serves as a tool for batch-level quality control.
DSSTox_CID_31610 CoA mostly includes findings from lab analyses of a specific batch. For each DSSTox_CID_31610 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
DSSTox_CID_31610 may be tested according to a variety of international standards, such as European Pharmacopoeia (DSSTox_CID_31610 EP), DSSTox_CID_31610 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (DSSTox_CID_31610 USP).
